FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2588395027> ?p ?o ?g. }

• W2588395027 endingPage "216" @default.
• W2588395027 startingPage "208" @default.
• W2588395027 abstract "Leiomyosarcoma, a rare tumor subtype, accounts for 1% of all uterine malignancies, but contributes to a significant proportion of uterine cancer deaths. Surgery is considered the mainstay of treatment for all soft tissue sarcomas, including uterine variants. However, uterine leiomyosarcoma is challenging to diagnose preoperatively and can mimic the appearance of benign uterine leiomyomas. Recently, concerns have grown in this regard, as surgeons have utilized uterine morcellation and myomectomy procedures unknowingly in the setting of occult uterine sarcoma. Because of aggressive tumor biology and relative chemotherapy and radiotherapy resistance, efficacious therapies to achieve prolonged survival or cure in those with both early and advanced-stage uterine leiomyosarcoma have been elusive. The strongest determinant of survival remains stage at diagnosis, though prediction models may provide a more accurate prognosis. Given the aggressive nature of this sarcoma subtype, novel early detection strategies and targeted therapies are the focus of several recently published and ongoing studies. While gemcitabine/docetaxel and doxorubicin remain the most active regimens in the treatment of advanced or recurrent disease, currently available cytotoxic regimens remain inadequate, with 5-year disease-specific survival of <30%. Pazopanib, trabectedin and olaratumab, are FDA-approved, targeted therapies with activity in uterine and other leiomyosarcomas, while aromatase inhibitors and immunotherapies are under active investigation. This review provides a critical appraisal of the literature regarding the contemporary surgical and medical management of uterine leiomyosarcoma, the role of targeted therapies, and the implications of uterine morcellation on gynecologic surgical practice." @default.
• W2588395027 created "2017-02-24" @default.
• W2588395027 creator A5018166981 @default.
• W2588395027 creator A5050465341 @default.
• W2588395027 creator A5082100490 @default.
• W2588395027 date "2017-04-01" @default.
• W2588395027 modified "2023-10-17" @default.
• W2588395027 title "Uterine leiomyosarcoma: Epidemiology, contemporary treatment strategies and the impact of uterine morcellation" @default.
• W2588395027 cites W106182599 @default.
• W2588395027 cites W1489305676 @default.
• W2588395027 cites W1502045029 @default.
• W2588395027 cites W1528500075 @default.
• W2588395027 cites W1666806394 @default.
• W2588395027 cites W1803625865 @default.
• W2588395027 cites W1877944058 @default.
• W2588395027 cites W1966048683 @default.
• W2588395027 cites W1975732673 @default.
• W2588395027 cites W1984378867 @default.
• W2588395027 cites W1984902398 @default.
• W2588395027 cites W1986741170 @default.
• W2588395027 cites W1988762768 @default.
• W2588395027 cites W1998248038 @default.
• W2588395027 cites W2004001144 @default.
• W2588395027 cites W2007484611 @default.
• W2588395027 cites W2021377616 @default.
• W2588395027 cites W2022508446 @default.
• W2588395027 cites W2024019506 @default.
• W2588395027 cites W2029810285 @default.
• W2588395027 cites W2030541266 @default.
• W2588395027 cites W2031391627 @default.
• W2588395027 cites W2032195218 @default.
• W2588395027 cites W2033168622 @default.
• W2588395027 cites W2037799221 @default.
• W2588395027 cites W2037836317 @default.
• W2588395027 cites W2046806366 @default.
• W2588395027 cites W2055216197 @default.
• W2588395027 cites W2056900647 @default.
• W2588395027 cites W2060895401 @default.
• W2588395027 cites W2063091276 @default.
• W2588395027 cites W2064136894 @default.
• W2588395027 cites W2071123235 @default.
• W2588395027 cites W2077362005 @default.
• W2588395027 cites W2082063053 @default.
• W2588395027 cites W2082479412 @default.
• W2588395027 cites W2101776780 @default.
• W2588395027 cites W2102905157 @default.
• W2588395027 cites W2110891275 @default.
• W2588395027 cites W2119679072 @default.
• W2588395027 cites W2122420323 @default.
• W2588395027 cites W2123036742 @default.
• W2588395027 cites W2130749589 @default.
• W2588395027 cites W2136309235 @default.
• W2588395027 cites W2140292293 @default.
• W2588395027 cites W2140377151 @default.
• W2588395027 cites W2144530818 @default.
• W2588395027 cites W2155597252 @default.
• W2588395027 cites W2158644353 @default.
• W2588395027 cites W2158705348 @default.
• W2588395027 cites W2161170571 @default.
• W2588395027 cites W2165422610 @default.
• W2588395027 cites W2167352270 @default.
• W2588395027 cites W2222024717 @default.
• W2588395027 cites W2236777922 @default.
• W2588395027 cites W2258277147 @default.
• W2588395027 cites W2259548176 @default.
• W2588395027 cites W2305520422 @default.
• W2588395027 cites W2325172660 @default.
• W2588395027 cites W2331482913 @default.
• W2588395027 cites W2331809926 @default.
• W2588395027 cites W2332156026 @default.
• W2588395027 cites W2413552560 @default.
• W2588395027 cites W2474878407 @default.
• W2588395027 cites W2601758528 @default.
• W2588395027 cites W4231814132 @default.
• W2588395027 doi "https://doi.org/10.1016/j.ygyno.2017.02.019" @default.
• W2588395027 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28209496" @default.
• W2588395027 hasPublicationYear "2017" @default.
• W2588395027 type Work @default.
• W2588395027 sameAs 2588395027 @default.
• W2588395027 citedByCount "131" @default.
• W2588395027 countsByYear W25883950272017 @default.
• W2588395027 countsByYear W25883950272018 @default.
• W2588395027 countsByYear W25883950272019 @default.
• W2588395027 countsByYear W25883950272020 @default.
• W2588395027 countsByYear W25883950272021 @default.
• W2588395027 countsByYear W25883950272022 @default.
• W2588395027 countsByYear W25883950272023 @default.
• W2588395027 crossrefType "journal-article" @default.
• W2588395027 hasAuthorship W2588395027A5018166981 @default.
• W2588395027 hasAuthorship W2588395027A5050465341 @default.
• W2588395027 hasAuthorship W2588395027A5082100490 @default.
• W2588395027 hasConcept C121608353 @default.
• W2588395027 hasConcept C126322002 @default.
• W2588395027 hasConcept C141071460 @default.
• W2588395027 hasConcept C142724271 @default.
• W2588395027 hasConcept C143998085 @default.
• W2588395027 hasConcept C2777532014 @default.
• W2588395027 hasConcept C2777590123 @default.

• next